{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:07:55Z","timestamp":1794960475129,"version":"4.9.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Transcatheter mitral valve replacement (TMVR) has become a feasible alternative to surgical mitral valve replacement (SMVR) in selected patients at high surgical risk. The risk of valve thrombosis following SMVR and TMVR, and the optimal antithrombotic therapy following these procedures, remains uncertain. We aimed to compare the incidence of bioprosthetic mitral valve thrombosis (bMVT) after SMVR and TMVR, and the incidence of bMVT between patients on different antithrombotic regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A literature search of Medline, Embase, and Cochrane Library was performed between January 2000 and August 2024. Random-effects models were used to derive pooled estimates of the incidence of bMVT in the absence of prior or active endocarditis and valve thrombosis. A total of 47 studies (6170 patients, total follow-up 9541.8 patient-years) were eligible for inclusion. The overall incidence of bMVT was 5.05 [95% confidence interval (CI) 3.18\u20138.01, I2\u00a0=\u00a082%] per 100-patient-years. Subclinical bMVT was more common than clinically significant bMVT: incidence 19.11\u00a0vs. 7.91 per 100-patient-years, adjusted incidence rate ratio (aIRR) 4.62 (95% CI 1.39\u201315.36), P\u00a0=\u00a00.012. bMVT was numerically more common after TMVR than SMVR, but the comparison was not statistically significant: incidence 7.03\u00a0vs. 0.58 per 100-patient-years, aIRR 2.19 (95% CI 0.72\u20136.72), P\u00a0=\u00a00.170. Patients on vitamin-K antagonists (VKA) had a lower incidence of bMVT than patients on direct oral anticoagulants (DOAC; incidence 5.72\u00a0vs. 17.08, aIRR 0.31, 95% CI 0.13\u20130.73, P\u00a0=\u00a00.007).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>bMVT is not uncommon, with numerically higher incidence in transcatheter compared to surgical valves, but the comparison was not statistically significant. VKAs are associated with a lower incidence of bMVT compared to DOACs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvaf005","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T23:14:20Z","timestamp":1738538060000},"page":"251-263","source":"Crossref","is-referenced-by-count":16,"title":["Valve thrombosis and antithrombotic therapy after bioprosthetic mitral valve replacement: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-1518","authenticated-orcid":false,"given":"Mark J","family":"Zorman","sequence":"first","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]},{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Vibhishanan","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dangas","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Castle","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Hou Christien","family":"Li","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Coronelli","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Eastwick-Jones","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Swan","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Johnson","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Choksey","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Yan","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam G C","family":"Scott","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Henry","sequence":"additional","affiliation":[{"name":"Health Care Libraries, University of Oxford, John Radcliffe Hospital , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Philip","family":"Cassar","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Barnes","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Ferreira-Martins","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-8309","authenticated-orcid":false,"given":"James","family":"Newton","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-0570","authenticated-orcid":false,"given":"Sam","family":"Dawkins","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjit","family":"Rihal","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6082-5379","authenticated-orcid":false,"given":"Mackram F","family":"Eleid","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-3150","authenticated-orcid":false,"given":"Sorin V","family":"Pislaru","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra E","family":"Guerrero","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Cardiovascular Medicine, , 200 First Street SW, Rochester, Minnesota 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ordonez-Mena","sequence":"additional","affiliation":[{"name":"University of Oxford Nuffield Department of Primary Care Sciences, , Radcliffe Observatory Quarter, Woodstock Road, OX2 6GG ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Cahill","sequence":"additional","affiliation":[{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"2025050208021786300_bib1","doi-asserted-by":"publisher","first-page":"e016086","DOI":"10.1161\/JAHA.120.016086","article-title":"Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era: a nationwide perspective","volume":"9","author":"Messika-Zeitoun","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025050208021786300_bib2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heartjnl-2020-318482","article-title":"Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation","volume":"107","author":"Cahill","year":"2021","journal-title":"Heart"},{"key":"2025050208021786300_bib3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"key":"2025050208021786300_bib4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/EURHEARTJ\/EHY590","article-title":"Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification","volume":"40","author":"Yoon","year":"2019","journal-title":"Eur Heart J"},{"key":"2025050208021786300_bib5","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/J.JCIN.2023.06.041","article-title":"5-Year prospective evaluation of mitral valve-in-valve, valve-in-ring, and valve-in-MAC outcomes: MITRAL trial final results","volume":"16","author":"Guerrero","year":"2023","journal-title":"JACC: Cardiovasc Interv"},{"key":"2025050208021786300_bib6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA Guideline for the management of patients with valvular Heart disease: executive Summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"60","author":"Beyersdorf","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025050208021786300_bib8","doi-asserted-by":"publisher","DOI":"10.1161\/circ.132.suppl_3.12262","article-title":"Clinical and echocardiographic predictors of bioprosthetic valve thrombosis","volume":"132","author":"Egbe","year":"2015","journal-title":"Circulation"},{"key":"2025050208021786300_bib9","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.jacc.2016.09.958","article-title":"Prosthetic heart valve thrombosis","volume":"68","author":"Dangas","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut","year":"2007","journal-title":"Heart"},{"key":"2025050208021786300_bib12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease","volume":"144","author":"Calabr\u00f2","year":"2021","journal-title":"Circulation"},{"key":"2025050208021786300_bib13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamacardio.2022.1591","article-title":"Subclinical leaflet thrombosis and anticoagulation after Transcatheter aortic valve replacement: a review","volume":"7","author":"Cahill","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025050208021786300_bib14","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.jcin.2021.09.019","article-title":"Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis","volume":"14","author":"Bogyi","year":"2021","journal-title":"JACC: Cardiovasc Interv"},{"key":"2025050208021786300_bib15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"J Am Med Assoc"},{"key":"2025050208021786300_bib16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jacc.2022.06.002","article-title":"Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement: JACC State-of-the-art review","volume":"80","author":"Pibarot","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2025050208021786300_bib18","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/sim.1221","article-title":"A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials","volume":"21","author":"Baujat","year":"2002","journal-title":"Stat Med"},{"key":"2025050208021786300_bib19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"2025050208021786300_bib20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Methods"},{"key":"2025050208021786300_bib21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evidence Based Mental Health"},{"key":"2025050208021786300_bib22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1161\/01.cir.103.11.1535","article-title":"Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation","volume":"103","author":"Puvimanasinghe","year":"2001","journal-title":"Circulation"},{"key":"2025050208021786300_bib23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779","article-title":"Treatment and clinical outcomes of transcatheter heart valve thrombosis","volume":"8","author":"Latib","year":"2015","journal-title":"Circ: Cardiovasc Interv"},{"key":"2025050208021786300_bib24","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib25","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.jacc.2020.03.022","article-title":"Bioprosthetic aortic valve leaflet thickening in the Evolut low risk sub-study","volume":"75","author":"Blanke","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4244\/eijv5i1a12","article-title":"Anatomo-pathological analysis after CoreValve Revalving system implantation","volume":"5","author":"Noble","year":"2009","journal-title":"EuroIntervention"},{"key":"2025050208021786300_bib27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/EJCTS\/EZU201","article-title":"Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series","volume":"47","author":"Pislaru","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025050208021786300_bib28","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736%2817%2930757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"key":"2025050208021786300_bib29","doi-asserted-by":"publisher","first-page":"e001608","DOI":"10.1136\/openhrt-2021-001608","article-title":"Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection","volume":"8","author":"Naser","year":"2021","journal-title":"Open Heart"},{"key":"2025050208021786300_bib30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.hlc.2022.02.011","article-title":"Immobile leaflets at time of bioprosthetic valve implantation: a novel risk factor for early bioprosthetic failure: a novel risk factor for early bioprosthetic failure","volume":"31","author":"Naser","year":"2022","journal-title":"Heart Lung Circ"},{"key":"2025050208021786300_bib31","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1016\/j.jbiomech.2015.07.031","article-title":"Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: a fatigue simulation study","volume":"48","author":"Martin","year":"2015","journal-title":"J Biomech"},{"key":"2025050208021786300_bib32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.121.058339","article-title":"Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes","volume":"146","author":"Fukui","year":"2022","journal-title":"Circulation"},{"key":"2025050208021786300_bib33","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.jcin.2017.03.039","article-title":"Not all immobile bioprosthetic valve cusps are thrombosed","volume":"10","author":"Waterbury","year":"2017","journal-title":"JACC: Cardiovasc Interv"},{"key":"2025050208021786300_bib34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/J.JACC.2018.12.066","article-title":"Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients","volume":"73","author":"Sorajja","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib35","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/J.JACC.2021.08.060","article-title":"2-Year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation","volume":"78","author":"Muller","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib36","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es","year":"2020","journal-title":"N Engl J Med"},{"key":"2025050208021786300_bib37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jacc.2023.10.031","article-title":"Comparison of direct oral anticoagulants vs vitamin K antagonists after transcatheter mitral valve replacement","volume":"83","author":"El Beze","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025050208021786300_bib38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2024.02.012","article-title":"Contemporary 1-year outcomes of mitral valve-in-ring with balloon-expandable aortic transcatheter valves in the U.S","volume":"17","author":"Guerrero","year":"2024","journal-title":"JACC Cardiovasc Interv"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvaf005\/61753739\/pvaf005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/3\/251\/61753739\/pvaf005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/3\/251\/61753739\/pvaf005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T09:33:07Z","timestamp":1746178387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/11\/3\/251\/7998924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2,4]]},"published-print":{"date-parts":[[2025,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf005","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,4]]}}}